{
    "pmcid": "10692239",
    "qa_pairs": {
        "How does DeepAssembly improve the accuracy of multi-domain protein structure predictions?": [
            "By using a divide-and-conquer strategy and predicting inter-domain interactions with AffineNet.",
            "By increasing the number of training datasets for single-domain proteins.",
            "By focusing solely on intra-chain accuracy without considering inter-domain interactions.",
            "By employing a single-step prediction process for entire protein complexes."
        ],
        "In what way does DeepAssembly complement AlphaFold-Multimer?": [
            "DeepAssembly offers strengths in scenarios with limited computational resources or when specific inter-domain interactions are crucial.",
            "DeepAssembly provides better predictions for single-domain proteins than AlphaFold-Multimer.",
            "DeepAssembly is more accurate in predicting the primary sequence of proteins.",
            "DeepAssembly requires more computational resources than AlphaFold-Multimer."
        ],
        "What is the primary limitation of AlphaFold2 that DeepAssembly aims to address?": [
            "AlphaFold2 struggles with predicting multi-domain protein structures due to its training bias on single-domain structures.",
            "AlphaFold2 is unable to predict any protein structures accurately.",
            "AlphaFold2 requires excessive computational resources for single-domain proteins.",
            "AlphaFold2 cannot predict the primary sequence of proteins."
        ],
        "What is the role of AffineNet in the DeepAssembly protocol?": [
            "AffineNet predicts inter-domain interactions crucial for accurate domain assembly.",
            "AffineNet predicts the primary sequence of proteins.",
            "AffineNet enhances the computational speed of single-domain predictions.",
            "AffineNet is used to visualize protein structures in 3D."
        ],
        "What potential advantage does DeepAssembly offer for SARS-CoV-2 nanobody design?": [
            "It provides more reliable structural models for virtual screening and molecular dynamics simulations.",
            "It reduces the need for experimental validation of nanobody binders.",
            "It eliminates the requirement for any computational resources.",
            "It guarantees the discovery of effective nanobody binders without further testing."
        ]
    }
}